From: Relation between regional and global systolic function in patients with ischemic cardiomyopathy after β-Blocker therapy or revascularization
β-blocker therapy
Revascularization
Baseline
Follow-up
LVEDV (ml)
271 ± 63
254 ± 55
238 ± 48
250 ± 59
LVESV (ml)
190 ± 63
163 ± 54*
152 ± 35
140 ± 41*
LVEF (%)
31 ± 7
37 ± 9*
36 ± 6
44 ± 6*